| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/19/2014 | EP2696683A1 Compositions and therapeutic uses of ikk-related kinase epsilon and tankbinding kinase 1 inhibitors |
| 02/19/2014 | CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| 02/19/2014 | CN103588714A Potassium hydroxide promoted 2-aryl quinazolone quinazolinone synthesis method |
| 02/19/2014 | CN103588713A Multi-target ubenimex prodrug derivative, as well as preparation method and application thereof |
| 02/19/2014 | CN103588712A Pyrimidine compound and preparation method and application thereof |
| 02/19/2014 | CN102066336B 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides |
| 02/19/2014 | CN102007104B The polymorphs of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof |
| 02/19/2014 | CN101589028B Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production |
| 02/18/2014 | US8653267 Co-crystal compound of optical device |
| 02/18/2014 | US8653266 Process for the production of etravirine |
| 02/18/2014 | US8653265 Preparation method of rosuvastatin calcium and its intermediates |
| 02/18/2014 | US8653264 Crystal of erlotinib base and the preparation method thereof |
| 02/18/2014 | US8653263 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| 02/18/2014 | US8653260 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/18/2014 | US8653067 Pharmaceutical composition for treating Alzheimer's disease |
| 02/18/2014 | US8653002 Aqueous suspension concentrate formulations containing saflufenacil |
| 02/18/2014 | US8652364 Polymer film, ultraviolet absorber, merocyanine compound and process for preparing merocyanine compound |
| 02/18/2014 | CA2563831C Monocyclic heterocycles as kinase inhibitors |
| 02/13/2014 | WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance |
| 02/13/2014 | WO2014023813A1 Alkylpyrimidine derivatives for the treatment of viral infections and further diseases |
| 02/13/2014 | WO2014023723A1 Subtituted azines as pesticides |
| 02/13/2014 | WO2014023691A1 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 02/13/2014 | WO2014023681A1 A process for the preparation of an intermediate for a triazolopyrimidine carbonucleoside |
| 02/13/2014 | WO2014023027A1 Erlotinib hydrochloride polymorph and preparation method therefor |
| 02/13/2014 | US20140046053 Neprilysin inhibitors |
| 02/13/2014 | US20140045871 Process for synthesis of phenoxy diaminopyrimidine derivatives |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |
| 02/13/2014 | US20140045848 Thiopyrimidine-based compounds and uses thereof |
| 02/13/2014 | US20140045802 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/13/2014 | US20140044806 New positive allosteric modulators of nicotinic acetylcholine receptor |
| 02/12/2014 | EP2695882A1 Organic compound, charge transport material, composition containing said compound, organic electroluminescent element, display device, and lighting device |
| 02/12/2014 | EP2694486A1 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 02/12/2014 | EP2694485A1 Combinations of akt inhibitor compounds and vemurafenib, and methods of use |
| 02/12/2014 | EP2694484A1 Pyrimidine derivatives for the treatment of viral infections |
| 02/12/2014 | EP2694073A1 Combinations of akt and mek inhibitor compounds, and methods of use |
| 02/12/2014 | EP2694072A1 Combinations of akt inhibitor compounds and abiraterone, and methods of use |
| 02/12/2014 | EP2694071A1 Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use |
| 02/12/2014 | EP2694070A1 Combinations of akt inhibitor compounds and erlotinib, and methods of use |
| 02/12/2014 | EP2693881A1 Substituted n-phenylpyrimidin-2-amine analogs as inhibitors of the axl kinase |
| 02/12/2014 | CN203429089U Cyclization reaction dehydrating device |
| 02/12/2014 | CN103582630A Neprilysin inhibitors |
| 02/12/2014 | CN103582629A 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/2-pyrimidine-carborxamides as MGLUR5 modulators |
| 02/12/2014 | CN103570634A Erlotinib hydrochloride polymorphic substance and preparation method thereof |
| 02/12/2014 | CN103570633A Preparation method of gefitinib |
| 02/12/2014 | CN103570632A Synthesis method of catalyst-free 4(3H)-quinazolinone |
| 02/12/2014 | CN103570631A Preparation method of tritiated diaveridine |
| 02/12/2014 | CN103570630A Heterocyclic nitrogen derivative and application thereof in medicines |
| 02/12/2014 | CN103570629A Benzanthracene derivatives containing pyrimidinyl, pyrazinyl or triazinyl groups and applications thereof |
| 02/12/2014 | CN103570628A Benzoindenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application |
| 02/12/2014 | CN103570627A Indenofluorene derivative containing pyrimidyl or pyrazinyl or triazinyl group, and its application |
| 02/12/2014 | CN103570626A Salt of dihydropyrimidine derivative |
| 02/12/2014 | CN103570589A Synthesis and preparation of salicylaldehyde-sulfanilamide derivative and application of salicylaldehyde-sulfanilamide derivative in anti-cancer drugs |
| 02/11/2014 | US8648191 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/11/2014 | US8648087 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 02/11/2014 | US8648073 Certain dipeptidyl peptidase inhibitors |
| 02/11/2014 | US8647603 Devices and methods for the treatment of cancer |
| 02/11/2014 | CA2720848C 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides |
| 02/11/2014 | CA2685215C Compounds and methods useful for treating asthma and allergic inflammation |
| 02/11/2014 | CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases |
| 02/06/2014 | WO2014022728A1 Substituted 5 - (quinazolin - 2 - yl) pyrimidin- 2 -amine derivatives useful as pi3k/mtor inhibitors for the treatment of cancer |
| 02/06/2014 | WO2014019186A1 Antidiabetic tricyclic compounds |
| 02/06/2014 | WO2014019023A1 α7 NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS AND USES THEREOF-I |
| 02/06/2014 | WO2013171729A3 Aryl and heteroaryl amide compounds as ror gamma t modulator |
| 02/06/2014 | US20140039187 Cxcr4 antagonists for the treatment of medical disorders |
| 02/06/2014 | US20140038993 New compounds |
| 02/06/2014 | US20140038990 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
| 02/06/2014 | US20140038952 Substituted Amino-Pyrimidine Derivatives |
| 02/06/2014 | US20140038948 Compounds and methods for kinase modulation, and indications therefor |
| 02/05/2014 | EP2691376A1 Fe(iii) complexes for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias |
| 02/05/2014 | CN103554111A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof |
| 02/05/2014 | CN103554038A Polyhalogenated benzonitrile quinazolone compounds, preparation method and use thereof |
| 02/05/2014 | CN103554037A Preparation method of bosentan metabolite (hydroxy bosentan) |
| 02/05/2014 | CN103554036A Preparation method of 2-chloro-4-substituted pyrimidine compound |
| 02/05/2014 | CN103554035A Preparation method of 4,6-dihalogenated pyridine-5-aldehyde |
| 02/05/2014 | CN103554011A Anthracene containing derivative as well as preparation method and application thereof |
| 02/05/2014 | CN103551144A Bimetallic composite catalyst for preparing afloqualone and method for preparing afloqualone |
| 02/04/2014 | US8642758 Process for preparation of erlotinib and its pharmaceutically acceptable salts |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642608 Quinazoline derivatives as VEGF inhibitors |
| 02/04/2014 | US8642601 Inhibitors of JNK |
| 02/04/2014 | CA2702297C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014016314A1 Fused quinonic compounds |
| 01/30/2014 | WO2014015935A2 Compounds and organic electronic devices |
| 01/30/2014 | WO2008019124A8 Heteroaryl compounds useful as inhibitors of e1 activating enzymes |
| 01/30/2014 | US20140031545 Organozinc complexes and processes for making and using the same |
| 01/30/2014 | US20140031373 Pyrimidine derivatives and use thereof as pesticides |
| 01/30/2014 | US20140031370 Amide derivatives, process for preparation thereof and use thereof as insecticide |
| 01/30/2014 | US20140031361 Inhibitors of protein kinases |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031355 Heterocyclic compounds and their uses |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/29/2014 | EP2690094A1 Fused quinonic compounds |